Showing results (241-250 of 283) with videos related to
Sort By:
Pageof 29
Lancet (London, England)|May 2, 1987
Hypothyroidism as a cause of acquired von Willebrand's diseaseR G Dalton, M S Dewar, G F Savidge, et al.Occupational and Environmental Medicine|February 23, 2005
The procoagulant potential of environmental particles (PM10)P S Gilmour, E R Morrison, M A Vickers, et al.American Journal of Epidemiology|December 22, 2006
Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer StudyE Roman, J Simpson, P Ansell, et al.Thrombosis Research|April 15, 1987
Lack of effect of a 24-hour infusion of iloprost in intermittent claudicationC R Hay, P C Waller, C Carter, et al.Orthopaedic Journal of Sports Medicine|February 14, 2022
The Role of Advanced Academic Degrees in Orthopaedic Sports Medicine FacultyAaron Z Chen, Kaylre M Greaves, Thomas A Fortney, et al.Oncogene|June 23, 2001
Characterization of germline TP53 splicing mutations and their genetic and functional analysisJ M Varley, C Attwooll, G White, et al.Oncogene|February 6, 1997
Absence of p53 permits propagation of mutant cells following genotoxic damageS D Griffiths, A R Clarke, L E Healy, et al.British Journal of Rheumatology|August 1, 1988
Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral diseaseM Greaves, R G Malia, A Milford Ward, et al.The Journal of Experimental Medicine|June 1, 1994
Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosisS D Griffiths, D T Goodhead, S J Marsden, et al.British Journal of Haematology|January 1, 1989
Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosisD A Lane, H Erdjument, A Flynn, et al.Pageof 29